Home > Insider Trading > Filing (0001601830-24-000204)

Filing Details

Accession Number:: 0001601830-24-000204
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-14 19:19:38
Reporting Period:: 2024-11-12

Accepted Time:: 2024-11-14 19:19:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1601830	Recursion Pharmaceuticals Inc.	RXRX	Biological Products, (No Disgnostic Substances) (2836)	464099738

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1855980	Michael Secora	C/O Recursion Pharmaceuticals 41 S. Rio Grande Street Salt Lake City UT 84101	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2024-11-12	39,375	$2.22	1,490,256	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-12	15,000	$7.64	1,475,256	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-11-13	39,375	$2.22	1,514,631	No	4	M	Direct
Class A Common Stock	Disposition	2024-11-13	15,000	$7.66	1,499,631	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-11-12	39,375	$0.00	39,375	$2.22
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-11-13	39,375	$0.00	39,375	$2.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
377,010		2030-03-03	No	4	M	Direct
337,635		2030-03-03	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Option (Right to Buy)	$2.22		2030-03-03	685,177	Direct
Class A Common Stock	Stock Option (Right to Buy)	$11.40	2022-02-04	2032-02-04	3,914	Direct
Class A Common Stock	Stock Option (Right to Buy)	$11.40		2032-02-04	116,684	Direct
Class A Common Stock	Stock Option (Right to Buy)	$8.55		2033-02-01	404,857	Direct
Class A Common Stock	Stock Option (Right to Buy)	$10.09		2034-02-09	348,380	Direct

Expiration Date	Remaning Holdings	Nature of Ownership
2030-03-03	685,177	Direct
2032-02-04	3,914	Direct
2032-02-04	116,684	Direct
2033-02-01	404,857	Direct
2034-02-09	348,380	Direct

Footnotes

Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024.
This transaction was executed in multiple trades at prices ranging from $7.49 to $8.01 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $7.31 to $7.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events.
The option, originally for 1,125,000 shares, vests as to one forty-eighth (1/48th) of the shares subject to the award one month after March 1, 2020, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.